Lung Cancer-Targeted [131I]-Iodoshikonin as Theranostic Agent: Radiolabeling, In Vivo Pharmacokinetics and Biodistribution
Crossref DOI link: https://doi.org/10.1007/s11094-022-02553-x
Published Online: 2022-02-11
Published Print: 2022-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Selim, Adli A.
Motaleb, M. A.
Fayez, Hend A.
Text and Data Mining valid from 2022-02-01
Version of Record valid from 2022-02-01
Article History
Received: 2 December 2020
First Online: 11 February 2022